First closing of $27 million Series A financing - - Fundingwill support Phase 1b/2a clinical trial of MVB-101, a prostate-specific membrane antigen x folate receptor alpha (PSMA ...
In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational ...
ZW191 demonstrates compelling anti-tumor activity in platinum-resistant ovarian cancer patients regardless of FRα expression levelConfirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results